Equities

Toho Holdings Co Ltd

Toho Holdings Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)3,838.00
  • Today's Change-5.00 / -0.13%
  • Shares traded235.10k
  • 1 Year change+46.77%
  • Beta0.1639
Data delayed at least 20 minutes, as of Jun 14 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.

  • Revenue in JPY (TTM)1.48tn
  • Net income in JPY20.66bn
  • Incorporated1948
  • Employees7.70k
  • Location
    Toho Holdings Co Ltd5-2-1, DaizawaSETAGAYA-KU 155-8655JapanJPN
  • Phone+81 334197811
  • Fax+81 334146042
  • Websitehttps://www.tohohd.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Neuca SA460.40bn5.96bn151.61bn5.19k26.043.6913.930.329334.2534.252,647.46241.932.377.477.172,307,345.003.303.5812.2713.3111.1910.331.391.430.50344.220.303234.595.178.796.588.95-3.0714.40
Guangxi LiuYao Group Co Ltd460.97bn19.28bn163.59bn5.58k7.690.9885--0.35492.462.4658.8219.121.076.991.973,807,204.004.805.0611.7312.2111.5611.854.474.401.305.260.543429.909.2312.1821.119.97-8.636.26
Herbalife Ltd798.67bn21.59bn172.60bn9.20k8.00--4.350.21611.371.3750.57-10.391.902.2558.67551,586.905.1411.308.6818.7076.8078.432.706.020.76672.981.760.00-2.730.688-55.74-13.679.95--
Sigma Healthcare Ltd355.79bn469.47m197.09bn156.00293.672.0956.280.5540.0040.0043.340.55442.6811.3710.52--0.41620.57340.6250.97629.179.520.15540.20221.861.590.1354184.52-9.16-3.46148.98-34.19-46.55-21.93
GuangYuYuan Chinese Herbal Medicn Co Ltd27.29bn2.64bn238.68bn1.81k90.507.16--8.740.24840.24842.573.140.47010.76611.99694,836.904.96-2.107.42-3.1671.4369.7410.56-6.001.1612.910.1569--13.56-4.53136.03-24.78-58.35--
Tibet Rhodiola Pharmaceutical Holding Co63.59bn17.58bn252.11bn601.0012.852.44--3.962.812.819.6514.760.60161.816.684,877,892.0016.8312.4423.1815.7193.6890.5127.9720.432.797.960.171650.4122.6924.98116.5630.01-1.4848.97
Toho Holdings Co Ltd1.48tn20.66bn293.34bn7.70k13.370.966410.860.1987287.12287.1220,513.863,971.511.9815.194.55--2.781.987.164.738.078.381.401.041.08--0.108115.616.353.8651.568.30-0.09493.71
China Meheco Group Co Ltd760.68bn20.06bn346.86bn8.39k17.291.37--0.4560.61830.618323.447.830.92244.582.284,180,309.002.963.406.727.7611.2214.153.212.931.228.890.33528.223.284.6042.45-7.466.72-1.02
China Medical System Holdings Ltd173.89bn52.10bn353.43bn5.70k6.821.056.232.031.051.053.526.820.45173.426.191,513,723.0013.4418.4415.7021.1476.2475.4729.7634.263.98--0.077240.14-12.438.08-26.335.3538.695.19
Suzuken Co Ltd2.39tn29.02bn360.33bn13.43k13.030.864411.270.151355.82355.8229,434.285,361.972.0115.634.51--2.441.756.604.567.767.831.220.8871.03----31.033.102.2842.62-0.799312.146.28
Alfresa Holdings Corporation2.86tn29.56bn430.02bn11.77k13.640.82613.870.1504155.44155.4414,905.272,566.512.0517.164.60--2.122.275.615.937.227.251.031.131.06--0.067936.436.021.6014.63-6.662.327.39
Data as of Jun 14 2024. Currency figures normalised to Toho Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

13.35%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 06 Jun 20242.03m2.65%
Nomura Asset Management Co., Ltd.as of 15 May 20241.92m2.52%
Norges Bank Investment Managementas of 31 Dec 20231.33m1.74%
Dimensional Fund Advisors LPas of 06 Jun 20241.20m1.58%
Nikko Asset Management Co., Ltd.as of 07 Jun 2024832.80k1.09%
BlackRock Fund Advisorsas of 06 Jun 2024805.00k1.05%
Daiwa Asset Management Co. Ltd.as of 31 May 2024795.20k1.04%
Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Jun 2024515.20k0.67%
Charles Schwab Investment Management, Inc.as of 05 Jun 2024382.96k0.50%
American Century Investment Management, Inc.as of 06 Jun 2024381.80k0.50%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.